Posted on 11/6/18
Tabula Rasa HealthCare Announces Third Quarter 2018 Operating Results
MOORESTOWN, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial . . .
Posted on 11/6/18
Why Teladoc Health Tanked Today
What happenedShares of Teladoc Health Inc. (NYSE:TDOC) tanked on Monday, dropping 12.7% as of the market close. There were two primary reasons behind the sell-off. First, . . .
Posted on 11/6/18
Tyme Provides Clinical and Corporate Update for Fiscal 2Q 2019
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate . . .
Posted on 11/5/18
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration
NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's . . .
Posted on 11/5/18
Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol, a once-daily, oral therapy for the . . .
Posted on 11/5/18
Check-Cap Reports Third Quarter 2018 Financial Results
Check-Cap Ltd. (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan, a preparation free capsule-based screening method for the . . .
Posted on 11/5/18
Advaxis Provides Update on Clinical Pipeline
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that it will be continuing . . .
Posted on 11/2/18
Evaluating Pfizer's Growth Plans And Valuation
SummaryPFE had a mild downside reaction to a minimal miss on Q3 sales.But the stock remains in an uptrend, having increased its price:sales ratio from 4X . . .
Posted on 11/2/18
Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock
MEDFORD, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI), a provider of point-of-care diagnostic tests for infectious diseases, announced today the pricing . . .
Posted on 11/2/18
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that . . .
Posted on 11/1/18
Eagle Pharmaceuticals Reports Third Quarter 2018 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced its financial results for the three and nine months ended September 30, 2018. Highlights of and . . .
Posted on 11/1/18
Cigna Reports Strong Third Quarter 2018 Results, Raises Outlook
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI) today reported third quarter 2018 results, with strong performance across all of our businesses. “Cigna continues to provide more affordable, . . .
Posted on 11/1/18
Zoetis Announces Third Quarter 2018 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2018 and updated its guidance for full year 2018.The company reported . . .
Posted on 11/1/18
Edge Therapeutics Reports Third Quarter 2018 Financial Results
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third . . .
Posted on 11/1/18
BioMarin Keeps on Pace for Its $2 Billion Goal
BioMarin Pharmaceutical (NASDAQ:BMRN) continues to see solid growth from its stable of drugs to treat orphan diseases as it pushes toward its goal for a combined . . .
Posted on 10/31/18
MeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health
LONDON and NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced an exclusive . . .
Posted on 10/31/18
Remedy Triples Size of its Episodes of Care Program with Healthcare Providers
Proven Success with Medicare’s Bundled Payments for Care Improvement Program Sets Stage for Success in Private Insurance Market With Self-Funded Employers, Commercial Payers and Providers Remedy, . . .
Posted on 10/31/18
Ophthotech Reports Third Quarter 2018 Financial and Operating Results
NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (Nasdaq:OPHT) today announced financial and operating results for the third quarter ended September 30, 2018 and provided a business update.“During 2018 Ophthotech . . .
Posted on 10/31/18
Pfizer (PFE) Q3 2018 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE) Q3 2018 Earnings Call October 30, 2018 10:00 AM ETExecutivesCharles E. Triano - Pfizer Inc.Ian C. Read - Pfizer Inc.Albert Bourla - Pfizer . . .
Posted on 10/31/18
Better Buy: Celgene Corporation vs. Gilead Sciences
It's been a terrifying month for biotech stocks across the board. The Nasdaq Biotechnology index has already tumbled 14% in October. That's brought some already attractive . . .
Posted on 10/30/18
Genesis Biotechnology Group Announces Partnership with Yale University
Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3) announced today that it has entered into a partnership with Yale University . . .
Posted on 10/30/18
Glenmark Pharmaceuticals Celebrates the Inauguration of its U.S. Manufacturing Site in Monroe, North Carolina
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the official inauguration of its manufacturing site in Monroe, North Carolina. The Monroe facility will serve as the . . .
Posted on 10/30/18
Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today provided preliminary financial results and announced that its Board of Directors has approved a new stock repurchase program . . .
Posted on 10/30/18
Schrödinger and WuXi AppTec Announce the Launch of Faxian Therapeutics
Schrödinger, a privately-held company revolutionizing drug discovery through advanced computational methods and enterprise software solutions, and WuXi AppTec, a leading pharmaceutical and medical device R&D enabling . . .
Posted on 10/30/18
Biological Industries USA Adds Human Mesenchymal Cells to its Stem Cell Portfolio in Partnership with StemExpress
CROMWELL, Conn. & FOLSOM, Calif.--(BUSINESS WIRE)--Biological Industries USA (BI-USA), a division of Biological Industries Beit Haemek Israel (BI), and StemExpress announce a strategic partnership for the . . .

